Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR.

about

Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR.

Item

http://www.wikidata.org/entity/Q38912799

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR.

@en

type

Item

label

Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR.

@en

prefLabel

Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR.

@en

P1476

Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR

@en

P2093

Susan L Samson

http://www.w3.org/2001/XMLSchema#string

P2860

Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding

Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial.

Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.

IRS proteins and beta-cell function.

Expert consensus document: A consensus on the medical treatment of acromegaly.

Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study.

Clinical manifestations and diagnosis of acromegaly

Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.

Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly.

Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies.

P2888

s40265-016-0615-y

P304

1235-1243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-016-0615-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Susan L Samson

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013340277

http://www.w3.org/2001/XMLSchema#string

P698

27473537

http://www.w3.org/2001/XMLSchema#string

P921

hyperglycemia